Abstract
Purpose we investigate (a) the diffusion of digital solutions supporting the quality of life in cancer patients and their caregivers across cancer types and EU countries, (b) the key thematic areas on which they focus, and (c) their effectiveness in improving the quality of life with respect to traditional healthcare.
Methods We searched articles from Embase, Scopus and PubMed in the last decade, and assessed their quality according to mixed methods appraisal tool. We compared the effectiveness of such tools and discussed the main gaps that emerged.
Results 49 studies were included (31 quantitative randomized control trials, 9 quantitative non-randomized, 4 quantitative descriptive, 3 qualitative, and 2 mixed-methods). We observed a prevalence of studies from the Netherlands and Germany, and breast cancer patients are the most targeted by single-cancer type interventions. The key areas of interventions for e-health solutions are psychophysical well-being, management of physical distress, remote monitoring of vitals and symptoms, and empowerment and self-efficacy. The effectiveness of digital solutions is typically higher than traditional healthcare, especially for solutions focusing on psychosocial well-being.
Conclusions This review showed a growing interest in digital solutions aimed at making the life of cancer patients and their caregivers easier, and their healthcare more patient-centered. The effectiveness of such interventions varies, but all the solutions are well accepted among the participants. Our findings provide evidence of the untapped potential of these digital tools, and of the need for their integration in the daily routine of cancer patients and their caregivers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by European Union under the Erasmus+ KA210-ADU program
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Abstract, Introduction and Discussion revised for the sake fo clarity
Data availability
Data are available upon reasonable request to the corresponding author.
